New 2025 Growing adoption of pharmacologic maintenance therapy after allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a survey on behalf of the EBMT acute leukemia working party Group Acute Leukemia Working Party (ALWP) 1st listed author Iman Abou Dalle Journal Bone Marrow Transplant.
New 2025 Improved post-transplant outcomes since 2000 for Ph-positive acute lymphoblastic leukemia in first remission: A study from the EBMT Acute Leukemia Working Party Group Acute Leukemia Working Party (ALWP) 1st listed author Ali Bazarbachi Journal Hemasphere.
New 2025 The impact of ABO compatibility on allogeneic hematopoietic cell transplantation outcomes: a contemporary and comprehensive study from the transplant complications working party of the EBMT Group Transplant Complications Working Party (TCWP) 1st listed author Mustafa Güven Journal Bone Marrow Transplant.
New 2025 Outcomes of patients with Hodgkin lymphoma receiving Brentuximab Vedotin (BV) as maintenance therapy after ASCT according to previous exposure to BV. A retrospective analysis of the EBMT Lymphoma Working Party in collaboration with GELTAMO, FIL, LYSA, and Turkish Lymphoma Group Group Lymphoma Working Party (LWP) Other society 1st listed author Carmen Martínez Journal Bone Marrow Transplant.
New 2025 GVHD prophylaxis in matched related stem cell transplantation: Why post-transplant cyclophosphamide can be recommended a study by the EBMT transplant complications working party Group Transplant Complications Working Party (TCWP) 1st listed author Olaf Penack Journal Leukemia.
New 2025 Less frequent complications following CAR T-cell therapies: hemophagocytic lymphohistiocytosis, graft-versus-host disease, thrombotic microangiopathy, coagulation disorders and secondary malignancies: best practice recommendations from the EBMT Practice Harmonization and Guidelines Committee Group Practice Harmonisation and Guidelines Committee 1st listed author Guillermo Ortí Journal Bone Marrow Transplant.
New 2025 Better Outcome Following Younger Haploidentical Donor Versus Older Matched Unrelated Donor Transplant for Fit Patients With Acute Myeloid Leukemia Transplanted in First Remission: A Study From the Global Committee and the Acute Leukemia Working Party of the EBMT Group Acute Leukemia Working Party (ALWP) Global Committee 1st listed author Yishan Ye Journal Am J Hematol.
2025 Non-ICANS neurological complications after CAR T-cell therapies: recommendations from the EBMT Practice Harmonisation and Guidelines Committee Group Practice Harmonisation and Guidelines Committee 1st listed author Charlotte E Graham Journal Lancet Oncol.
2025 Pneumonia definition in allogeneic hematopoietic cell transplant recipients: Update and challenges in 2024. Recommendations from the EBMT Infectious Diseases Working Party and Practice Harmonization and Guidelines committee Group Infectious Diseases Working Party (IDWP) Practice Harmonisation and Guidelines Committee 1st listed author Dionysios Neofytos Journal Curr Res Transl Med.
2025 Current use of donor lymphocyte infusions after allogenic stem cell transplantation in Europe: a survey on behalf of the cellular therapy and immunobiology working party of the EBMT Group Cellular Therapy & Immunobiology Working Party (CTIWP) 1st listed author Nicole Santoro Journal Bone Marrow Transplant.
2025 Selecting patients with sickle cell disease for gene addition or gene editing-based therapeutic approaches: Report on behalf of a joint EHA Specialized Working Group and EBMT Hemoglobinopathies Working Party consensus conference Group Haemoglobinopathies Working Party (HWP) Other society 1st listed author Lucia de Franceschi Journal Hemasphere.
2025 Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Myeloid Leukemia With Myelodysplasia-Related Genetic Features: Relevance of the Genetic Underlying Category. A Retrospective Analysis on Behalf of the Acute Leukemia Working Party of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Jordi Esteve Journal Am J Hematol.